Reported Standalone quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 142.85 crore in June 2023 down 22.48% from Rs. 184.27 crore in June 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 8.21 crore in June 2023 down 172.06% from Rs. 11.39 crore in June 2022.
EBITDA stands at Rs. 4.83 crore in June 2023 down 82.85% from Rs. 28.16 crore in June 2022.
Astec Life shares closed at 1,234.10 on July 27, 2023 (NSE) and has given -18.95% returns over the last 6 months and -33.71% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'23 | Mar'23 | Jun'22 | | Net Sales/Income from operations | 142.85 | 126.97 | 184.27 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 142.85 | 126.97 | 184.27 | | EXPENDITURE | | Consumption of Raw Materials | 120.77 | 76.49 | 138.64 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -18.16 | 9.76 | -16.16 | | Power & Fuel | -- | -- | -- | | Employees Cost | 15.38 | 12.86 | 12.98 | | Depreciation | 9.40 | 7.77 | 8.94 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 21.72 | 22.47 | 23.35 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -6.27 | -2.37 | 16.51 | | Other Income | 1.70 | 2.57 | 2.71 | | P/L Before Int., Excpt. Items & Tax | -4.57 | 0.19 | 19.22 | | Interest | 6.47 | 6.41 | 3.93 | | P/L Before Exceptional Items & Tax | -11.03 | -6.21 | 15.29 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -11.03 | -6.21 | 15.29 | | Tax | -2.83 | -1.22 | 3.90 | | P/L After Tax from Ordinary Activities | -8.21 | -5.00 | 11.39 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -8.21 | -5.00 | 11.39 | | Equity Share Capital | 19.61 | 19.61 | 19.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -4.19 | -2.55 | 5.81 | | Diluted EPS | -4.19 | -2.55 | 5.81 | | EPS After Extra Ordinary | | Basic EPS | -4.19 | -2.55 | 5.81 | | Diluted EPS | -4.19 | -2.55 | 5.81 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
